|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Medidata Solutions, Inc. Prices Initial Public Offering
6/25/2009
NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced the pricing of its initial public offering of 6,300,000 shares of common stock at $14.00 per share. In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to 945,000 shares of common stock at the initial public offering price to cover over-allotments, if any. Medidata’s common stock will commence trading on the NASDAQ Global Market on June 25, 2009, under the ticker symbol “MDSO.”
Citi and Credit Suisse Securities (USA) LLC acted as joint bookrunning managers for the proposed offering. Jefferies & Company, Inc. and Needham & Company, LLC acted as co-managers.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 24, 2009. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. A copy of the final prospectus may be obtained directly from:
Citi Brooklyn Army Terminal 140 58th Street, 8th Floor Brooklyn, N.Y. 11220 Telephone: (800) 831-9146 Telephone: (800) 221-1037
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor shall there be any sale, offer or solicitation of these securities in any state or jurisdiction in which such sale, offer or solicitation would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction.
Contact:
Investor Contact:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media Contact:
Lois Paul & Partners
Susan McCarron, 781-782-5767
susan_mccarron@lpp.com
|
|
|
|
|
|
|
|
|
|
|
|